Old Point Trust & Financial Services N A’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$903K Sell
32,161
-11,365
-26% -$303K 0.29% 73
2025
Q4
$1.08M Sell
43,526
-15,937
-27% -$402K 0.34% 64
2025
Q3
$1.52M Sell
59,463
-3,000
-5% -$74K 0.49% 52
2025
Q2
$1.51M Sell
62,463
-1,760
-3% -$41K 0.53% 43
2025
Q1
$1.63M Sell
64,223
-850
-1% -$22.2K 0.57% 41
2024
Q4
$1.73M Sell
65,073
-980
-1% -$26.6K 0.61% 40
2024
Q3
$1.91M Buy
66,053
+750
+1% +$21.9K 0.69% 39
2024
Q2
$1.83M Sell
65,303
-1,250
-2% -$34.4K 0.71% 38
2024
Q1
$1.85M Buy
66,553
+11,351
+21% +$315K 0.67% 39
2023
Q4
$1.59M Sell
55,202
-525
-0.9% -$15.9K 0.64% 38
2023
Q3
$1.85M Buy
55,727
+1,750
+3% +$61.9K 0.83% 35
2023
Q2
$1.98M Buy
53,977
+385
+0.7% +$15K 0.82% 34
2023
Q1
$2.19M Buy
53,592
+4,440
+9% +$192K 0.96% 32
2022
Q4
$2.52M Buy
49,152
+250
+0.5% +$12K 1.16% 27
2022
Q3
$2.14M Sell
48,902
-3,090
-6% -$150K 1.08% 28
2022
Q2
$2.73M Buy
51,992
+3,053
+6% +$156K 1.26% 28
2022
Q1
$2.53M Sell
48,939
-270
-0.5% -$14K 1.04% 32
2021
Q4
$2.91M Buy
49,209
+1,734
+4% +$85.9K 1.17% 29
2021
Q3
$2.04M Sell
47,475
-2,051
-4% -$90.9K 0.91% 36
2021
Q2
$1.94M Buy
49,526
+300
+0.6% +$11.7K 0.86% 36
2021
Q1
$1.78M Buy
49,226
+1,700
+4% +$60.4K 0.83% 36
2020
Q4
$1.75M Sell
47,526
-2,841
-6% -$104K 0.9% 33
2020
Q3
$1.75M Sell
50,367
-31
-0.1% -$1.09K 0.96% 33
2020
Q2
$1.56M Sell
50,398
-793
-2% -$26.9K 0.86% 35
2020
Q1
$1.58M Sell
51,191
-25,504
-33% -$869K 1% 33
2019
Q4
$2.85M Sell
76,695
-2,265
-3% -$80.7K 1.31% 33
2019
Q3
$2.69M Sell
78,960
-1,476
-2% -$53.7K 1.31% 33
2019
Q2
$3.31M Sell
80,436
-2,916
-3% -$116K 1.68% 24
2019
Q1
$3.36M Sell
83,352
-1,606
-2% -$64.3K 1.75% 23
2018
Q4
$3.52M Sell
84,958
-945
-1% -$39.2K 2.08% 19
2018
Q3
$3.59M Sell
85,903
-4,295
-5% -$165K 1.85% 21
2018
Q2
$3.1M Sell
90,198
-1,040
-1% -$35.5K 1.7% 24
2018
Q1
$3.07M Buy
91,238
+210
+0.2% +$7.22K 1.73% 24
2017
Q4
$3.13M Sell
91,028
-251
-0.3% -$8.56K 1.69% 23
2017
Q3
$3.09M Buy
91,279
+1,368
+2% +$44K 1.74% 23
2017
Q2
$2.87M Sell
89,911
-1,665
-2% -$52.5K 1.66% 23
2017
Q1
$2.97M Sell
91,576
-3,579
-4% -$113K 1.72% 23
2016
Q4
$2.93M Buy
95,155
+9,781
+11% +$299K 1.76% 23
2016
Q3
$2.74M Buy
85,374
+790
+0.9% +$26.4K 1.69% 23
2016
Q2
$2.83M Sell
84,584
-1,884
-2% -$60.1K 1.76% 23
2016
Q1
$2.43M Buy
86,468
+3,010
+4% +$86K 1.52% 28
2015
Q4
$2.56M Buy
83,458
+18,391
+28% +$579K 1.66% 25
2015
Q3
$1.94M Buy
65,067
+1,160
+2% +$37.2K 1.38% 29
2015
Q2
$2.03M Buy
63,907
+8,564
+15% +$279K 1.32% 31
2015
Q1
$1.83M Sell
55,343
-5,270
-9% -$168K 1.18% 33
2014
Q4
$1.79M Sell
60,613
-3,689
-6% -$106K 1.08% 34
2014
Q3
$1.8M Sell
64,302
-1,627
-2% -$45.7K 1.08% 34
2014
Q2
$1.86M Sell
65,929
-1,199
-2% -$34.2K 1.11% 32
2014
Q1
$2.05M Sell
67,128
-3,268
-5% -$97.4K 1.28% 30
2013
Q4
$2.05M Sell
70,396
-3,478
-5% -$101K 1.34% 30
2013
Q3
$2.01M Buy
73,874
+106
+0.1% +$2.88K 1.39% 31
2013
Q2
$1.96M Buy
+73,768
New +$2.04M 1.39% 31

Other funds holding PFE

Old Point Trust & Financial Services N A's PFE Position: Q1 2026 in Review

Old Point Trust & Financial Services N A reduced its Pfizer (PFE) stake by 26% in Q1 2026, selling an estimated $303K and leaving 32,161 shares worth $903K. The position accounts for 0.29% of the portfolio, ranked #73.

Old Point Trust & Financial Services N A first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.59M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Old Point Trust & Financial Services N A held 32,161 shares of Pfizer worth $903K as of Q1 2026.
  • Old Point Trust & Financial Services N A sold 11,365 Pfizer shares in Q1 2026, an estimated $303K.
  • Pfizer made up 0.29% of Old Point Trust & Financial Services N A's portfolio in Q1 2026, its #73 holding.
  • Old Point Trust & Financial Services N A first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Old Point Trust & Financial Services N A's Pfizer position peaked at $3.59M in Q3 2018.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Old Point Trust & Financial Services N A's 13F filing for Q1 2026, filed 22 Apr 2026.